Trulicity 0.75Mg/0.5Ml X 4Pen

Trulicity 0.75 mg Injection Pens (Dulaglutide) – 4 Prefilled Pens

Drug Overview

Trulicity 0.75 mg is a once-weekly injectable medication designed to improve blood sugar control in adults with type 2 diabetes mellitus. It contains dulaglutide, a GLP-1 receptor agonist that enhances insulin secretion and helps regulate glucose levels. Trulicity 0.75 mg offers a convenient weekly dosing schedule, making it easier for patients to maintain consistent diabetes management.

Active Ingredient and Composition

• Active ingredient: Dulaglutide
• Strength: 0.75 mg per prefilled pen
• Dosage form: Solution for subcutaneous injection
• Pack size: 4 prefilled pens (each pen contains one weekly dose)

Dulaglutide is a long-acting incretin mimetic that supports sustained glucose control over one week.

Drug Class

• GLP-1 Receptor Agonist (Incretin-based therapy)

Uses and Medical Indications of Trulicity 0.75 mg

Trulicity 0.75 mg is indicated for:

• Type 2 diabetes mellitus:
  • Improves blood glucose control
  • Reduces HbA1c levels
• Metabolic support:
  • May support weight reduction in some patients under medical supervision

This medication is not suitable for type 1 diabetes or diabetic ketoacidosis.

How Trulicity 0.75 mg Works

Dulaglutide mimics the action of the GLP-1 hormone, resulting in:

• Enhanced insulin release after meals
• Reduced glucagon secretion
• Delayed gastric emptying
• Reduced appetite and caloric intake

These combined effects help stabilize blood sugar levels and improve overall metabolic control.

Dosage and Administration

• Recommended starting dose: 0.75 mg once weekly
• Administered via subcutaneous injection
• Injection sites include the abdomen, thigh, or upper arm
• Each pen delivers a single weekly dose
• Can be used with or without meals

Always follow your healthcare provider’s instructions and do not adjust the dose without medical advice.

Possible Side Effects of Trulicity 0.75 mg

Common side effects include:

• Nausea
• Diarrhea
• Vomiting
• Loss of appetite
• Abdominal discomfort

Serious but rare side effects:

• Pancreatitis (severe abdominal pain)
• Severe gastrointestinal reactions
• Allergic reactions

Seek immediate medical attention if serious symptoms develop.

Contraindications

• Hypersensitivity to dulaglutide
• History of medullary thyroid carcinoma
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Drug Interactions

Trulicity 0.75 mg may interact with:

• Oral medications affected by delayed gastric emptying
• Insulin or sulfonylureas (risk of hypoglycemia)

Inform your doctor about all medications you are currently using.

Warnings and Precautions

• Use only under medical supervision
• Monitor blood sugar levels regularly
• Use caution in patients with gastrointestinal or pancreatic conditions
• Report any severe or unusual symptoms promptly

Use During Pregnancy and Breastfeeding

• Use only if clearly necessary and prescribed by a doctor
• Consult your healthcare provider before breastfeeding

Use for Children

• Not approved for pediatric use

Drug Alternatives

• Semaglutide
• Liraglutide
• Exenatide

Alternative selection depends on individual patient needs and treatment goals.

Comparison With Similar Drugs

• Trulicity 0.75 mg is ideal as a starting dose for diabetes management
• Offers once-weekly convenience
• Comparable efficacy to other GLP-1 receptor agonists with a favorable safety profile

Safe Usage Tips

• Store in a refrigerator at 2–8°C (do not freeze)
• Keep away from light
• Rotate injection sites regularly
• Do not share injection pens

Conclusion

Trulicity 0.75 mg provides an effective and convenient solution for managing type 2 diabetes with once-weekly dosing. When used correctly under medical supervision, it helps improve glycemic control and supports better long-term health outcomes.